Showing metabocard for (E)-2-methylbut-2-enoic-acid_N1-(3-aminopropyl)butane-1,4-diamine (MMDBc0061108)
Microbial
Human
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2025-10-03 03:34:29 UTC | ||||||||||||
| Update Date | 2025-10-08 21:35:46 UTC | ||||||||||||
| Metabolite ID | MMDBc0061108 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | (E)-2-methylbut-2-enoic-acid_N1-(3-aminopropyl)butane-1,4-diamine | ||||||||||||
| Description | (E)-2-methylbut-2-enoic-acid_N1-(3-aminopropyl)butane-1,4-diamine is a metabolite belonging to the class of amino acids and derivatives. There is limited literature available on this compound, indicating a gap in the understanding of its biological significance and potential applications. | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C12H25N3O | ||||||||||||
| Average Mass | 227.352 | ||||||||||||
| Monoisotopic Mass | 227.199762437 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | Not Available | ||||||||||||
| InChI Key | YNPDKBTYTOSZPN-QDEBKDIKSA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Not Available | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Not Available | |||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | This table shows at most 5 pathways. For the full list of associated pathways: See All Associated Bacterial Pathways
| ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| CMMC Knowledgebase | YNPDKBTYTOSZPN-QDEBKDIKSA-N | ||||||||||||
| References | |||||||||||||
| Synthesis Reference | Not Available | ||||||||||||
| General References |
| ||||||||||||
